Trexquant Investment LP Kura Oncology, Inc. Transaction History

Trexquant Investment LP

  • $8.06 Billion
  • Q4 2024

A detailed history of Trexquant Investment LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 566,945 shares of KURA stock, worth $4.68 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
566,945
Previous 58,583 867.76%
Holding current value
$4.68 Million
Previous $1.14 Million 331.64%
% of portfolio
0.06%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$8.51 - $19.21 $4.33 Million - $9.77 Million
508,362 Added 867.76%
566,945 $4.94 Million
Q3 2024

Nov 12, 2024
BUY
$18.57 - $23.23 $83,917 - $104,976
4,519 Added 8.36%
58,583 $1.14 Million
Q2 2024

Aug 13, 2024
BUY
$17.53 - $22.98 $619,825 - $812,526
35,358 Added 189.02%
54,064 $1.11 Million
Q1 2024

May 14, 2024
SELL
$13.42 - $23.53 $608,207 - $1.07 Million
-45,321 Reduced 70.78%
18,706 $398,000
Q4 2023

Feb 09, 2024
BUY
$7.58 - $14.38 $207,024 - $392,746
27,312 Added 74.39%
64,027 $920,000
Q3 2023

Nov 13, 2023
SELL
$8.44 - $11.86 $393,371 - $552,770
-46,608 Reduced 55.94%
36,715 $334,000
Q2 2023

Aug 11, 2023
BUY
$9.62 - $13.99 $801,567 - $1.17 Million
83,323 New
83,323 $881,000
Q3 2022

Nov 14, 2022
BUY
$12.01 - $19.45 $406,730 - $658,693
33,866 Added 171.26%
53,641 $733,000
Q2 2022

Aug 11, 2022
BUY
$10.71 - $18.33 $211,790 - $362,475
19,775 New
19,775 $362,000
Q1 2022

May 13, 2022
SELL
$11.78 - $16.98 $162,187 - $233,780
-13,768 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$12.22 - $19.57 $12,317 - $19,726
1,008 Added 7.9%
13,768 $193,000
Q3 2021

Nov 12, 2021
SELL
$15.42 - $21.72 $174,184 - $245,349
-11,296 Reduced 46.96%
12,760 $239,000
Q2 2021

Aug 12, 2021
BUY
$20.85 - $29.88 $339,771 - $486,924
16,296 Added 210.0%
24,056 $502,000
Q1 2021

May 13, 2021
SELL
$24.75 - $39.14 $361,721 - $572,031
-14,615 Reduced 65.32%
7,760 $219,000
Q4 2020

Feb 11, 2021
BUY
$29.0 - $41.62 $648,875 - $931,247
22,375 New
22,375 $731,000
Q3 2020

Nov 06, 2020
SELL
$16.3 - $30.64 $277,116 - $520,910
-17,001 Closed
0 $0
Q2 2020

Aug 07, 2020
SELL
$7.95 - $18.81 $111,975 - $264,938
-14,085 Reduced 45.31%
17,001 $277,000
Q1 2020

May 08, 2020
BUY
$6.45 - $14.04 $121,421 - $264,303
18,825 Added 153.54%
31,086 $309,000
Q4 2019

Feb 12, 2020
BUY
$12.97 - $15.94 $159,025 - $195,440
12,261 New
12,261 $169,000
Q4 2018

Feb 13, 2019
SELL
$10.6 - $17.49 $131,397 - $216,806
-12,396 Closed
0 $0
Q3 2018

Nov 09, 2018
BUY
$16.65 - $21.85 $206,393 - $270,852
12,396 New
12,396 $217,000

Others Institutions Holding KURA

# of Institutions
193
Shares Held
77.5M
Call Options Held
103K
Put Options Held
106K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $552M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email